Innovating Works

Ship Clones

Financiado
Ship Clones: Characterization and search for biomarker of marine transmissible c...
Ship Clones: Characterization and search for biomarker of marine transmissible cancers Clonally transmissible cancers are cell clones that are transmitted between individuals via the transfer of living cancer cells. There are only... Ship Clones: Characterization and search for biomarker of marine transmissible cancers Clonally transmissible cancers are cell clones that are transmitted between individuals via the transfer of living cancer cells. There are only three known types of naturally occurring clonally transmissible cancers, one of which is a disseminated neoplasia (DN) found in marine bivalves. DN is a leukemia-like cancer characterized by the proliferation of hypertrophied cells. In later stages of the disease, these cells spread throughout all tissues destroying their normal architecture and causing the death of their host organism. A polyphyletic origin of the DN has been detected in the common cockle Cerastoderma edule. DN has appeared on at least six different occasions and the six clones currently known coexist in cockle populations of the European Atlantic coast. In the present proposal high resolution lipidomics and proteomics will be used to screen for clonal biomarkers of DN and help to better understand the biological systems of transmissible cancers. Marine transmissible cancers are interesting biological models to better understand cancer transmissibility and metastasis. Marine clones likely ship using ocean currents to colonize new hosts in different regions. It is likely that they may also be unintentionally introduced by the action of man in disease-free regions. Hence, these cancers represent a potential threat for marine ecosystems, as they negatively impact keystone species (bivalves), that also have important socio-economic value for fisheries. As such, it is paramount to successfully identify, monitor and characterize the prevalence of clonal DN in marine bivalves, before any successful prevention and mitigation actions can be applied. ver más
31/08/2024
157K€
Duración del proyecto: 25 meses Fecha Inicio: 2022-07-20
Fecha Fin: 2024-08-31

Línea de financiación: concedida

El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2024-08-31
Línea de financiación objetivo El proyecto se financió a través de la siguiente ayuda:
Presupuesto El presupuesto total del proyecto asciende a 157K€
Líder del proyecto
UNIVERSIDADE DE AVEIRO No se ha especificado una descripción o un objeto social para esta compañía.
Perfil tecnológico TRL 4-5